Clinical Trials Browser

NIH × Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all

NCT00089609 2018-04-20

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Phase 2 Completed

73 enrolled 16 charts

Neoplasms, Prostatic Neoplasms